Surgical treatment of bone metastasis followed by a primary lung cancer lesion: report of a case.
In August 1997, a 68-year-old man presented with right pelvic pain. Pelvic computed tomography (CT) and bone scintigraphy showed a huge tumor of the right iliac bone. No other lesion was detected, in spite of a high serum carcinoembryonic antigen level (CEA, 963 ng/ml). In October 1997, the iliac bone tumor was widely resected, and thereafter was diagnosed to be a metastatic adenocarcinoma of unknown origin. After a resection, the serum CEA level dropped as low as 6.4 ng/ml, but gradually went up to 80 ng/ml in October 1999. Next, a lung tumor in the left upper lobe was detected by routine chest CT. In January 2000, a left upper lobectomy was performed, and based on not only the pathological findings but also on an immunohistochemical analysis for napsin A expression, the tumor was diagnosed to be lung adenocarcinoma. The histological and immunohistochemical findings in the previously resected bone lesion were completely compatible with those in the pulmonary tumor, which was finally regarded as M1 lung cancer. In October 2002, the patient was alive without any symptoms, although the serum CEA level was elevated again. We consider this case worthy of presentation because of its unique clinical course as well as the successful long-term survival after surgical treatment alone, for both the primary and metastatic lesions.
Higashiyama
Masahiko
M
Department of Thoracic Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan.
Kodama
Ken
K
Takami
Koji
K
Higaki
Naozumi
N
Yamada
Terumasa
T
Mano
Masayuki
M
Tsukamoto
Yoshitane
Y
Araki
Nobuhito
N
Yoshikawa
Hideki
H
D000230:Adenocarcinoma / Q000175:diagnosis / Q000378:metabolism / Q000556:secondary* / Q000601:surgery*; D000368:Aged; D016282:Aspartic Acid Endopeptidases / Q000378:metabolism; D001859:Bone Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000556:secondary* / Q000601:surgery*; D002272:Carcinoembryonic Antigen / Q000097:blood; D006801:Humans; D007085:Ilium; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D008297:Male; D011013:Pneumonectomy
D002272:Carcinoembryonic Antigen; D016282:Aspartic Acid Endopeptidases; C498549:NAPSA protein, human